We are live on ! Find out more
HAG

HighPoint Advisor Group Portfolio holdings

AUM $2.84B
1-Year Est. Return 31.94%
This Fund
S&P 500
This Quarter Est. Return
+8.4%
1 Year Est. Return
+31.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$993M
AUM Growth
+$129M
Cap. Flow
+$92.7M
Cap. Flow %
9.33%
Top 10 Hldgs %
30.04%
Holding
594
New
70
Increased
355
Reduced
101
Closed
33
Avg Time Held
9 quarters
Top 10 Avg Time Held
7.3 quarters
Top 20 Avg Time Held
12.9 quarters

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$5.38M
2
AAPL icon
Apple
AAPL
+$4.64M
3
JPM icon
JPMorgan Chase
JPM
+$4.48M
4
AMZN icon
Amazon
AMZN
+$3.83M
5
FSK icon
FS KKR Capital
FSK
+$3.18M

Top Sells

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$4.92M
2
FSKR
FS KKR Capital Corp. II
FSKR
+$3.37M
3
TSLA icon
Tesla
TSLA
+$1.2M
4
NWSA icon
News Corp Class A
NWSA
+$944K
5
NIO icon
NIO
NIO
+$835K

Sector Composition

Rank Sector Weight
1 Technology 25.84%
2 Financials 14.16%
3 Healthcare 13.02%
4 Consumer Discretionary 12.37%
5 Communication Services 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MRK icon
51
Merck
MRK
$359B
$4.22M 0.43%
54,294
+5,578
+11% +$415K
2015 Q3
23 quarters
FITB icon
52
Fifth Third Bancorp
FITB
$45.9B
$4.17M 0.42%
108,974
+3,546
+3% +$142K
2019 Q1
9 quarters
KO icon
53
Coca-Cola
KO
$379B
$4.15M 0.42%
76,713
+6,130
+9% +$334K
2015 Q2
24 quarters
CSCO icon
54
Cisco
CSCO
$467B
$4.09M 0.41%
77,126
+8,336
+12% +$439K
2014 Q4
26 quarters
BMY icon
55
Bristol-Myers Squibb
BMY
$121B
$3.93M 0.4%
58,831
+10,495
+22% +$684K
2015 Q3
23 quarters
TMO icon
56
Thermo Fisher Scientific
TMO
$243B
$3.91M 0.39%
7,755
+592
+8% +$279K
2016 Q2
20 quarters
BAC icon
57
Bank of America
BAC
$380B
$3.79M 0.38%
91,906
+18,240
+25% +$748K
2014 Q4
26 quarters
CVS icon
58
CVS Health
CVS
$110B
$3.61M 0.36%
43,249
+19,086
+79% +$1.56M
2015 Q3
23 quarters
RTX icon
59
RTX Corp
RTX
$251B
$3.49M 0.35%
40,873
+5,263
+15% +$443K
2015 Q4
22 quarters
AXP icon
60
American Express
AXP
$208B
$3.47M 0.35%
21,000
+3,339
+19% +$523K
2020 Q4
2 quarters
QCOM icon
61
Qualcomm
QCOM
$187B
$3.37M 0.34%
23,575
+2,280
+11% +$308K
2016 Q1
21 quarters
AMGN icon
62
Amgen
AMGN
$224B
$3.29M 0.33%
13,510
+1,059
+9% +$261K
2015 Q4
22 quarters
EXC icon
63
Exelon
EXC
$43B
$3.25M 0.33%
102,905
+4,542
+5% +$146K
2015 Q2
24 quarters
WPC icon
64
W.P. Carey
WPC
$14.4B
$3.23M 0.33%
44,177
+1,489
+3% +$109K
2018 Q2
12 quarters
NKE icon
65
Nike
NKE
$51.6B
$3.19M 0.32%
20,639
+3,030
+17% +$408K
2015 Q4
22 quarters
XYZ icon
66
Block Inc
XYZ
$46.4B
$3.18M 0.32%
13,055
-3,334
-20% -$773K
2016 Q4
18 quarters
NOC icon
67
Northrop Grumman
NOC
$68.3B
$3.15M 0.32%
8,667
+1,435
+20% +$517K
2016 Q2
20 quarters
TGT icon
68
Target
TGT
$69.8B
$3.13M 0.32%
12,952
+3,510
+37% +$768K
2015 Q3
23 quarters
OMF icon
69
OneMain Financial
OMF
$6.45B
$3.04M 0.31%
50,740
+3,787
+8% +$214K
2020 Q4
2 quarters
UNP icon
70
Union Pacific
UNP
$165B
$3M 0.3%
13,640
+979
+8% +$218K
2015 Q4
22 quarters
PINS icon
71
Pinterest
PINS
$12.1B
$2.98M 0.3%
37,714
-2,087
-5% -$146K
2020 Q3
3 quarters
AVGO icon
72
Broadcom
AVGO
$1.73T
$2.94M 0.3%
61,770
+11,580
+23% +$537K
2015 Q3
23 quarters
BRK.A icon
73
Berkshire Hathaway Class A
BRK.A
$1.11T
$2.93M 0.3%
7
– –
2015 Q3
23 quarters
MO icon
74
Altria Group
MO
$120B
$2.93M 0.29%
61,374
+920
+2% +$45.2K
2015 Q1
25 quarters
DOW icon
75
Dow Inc
DOW
$20.5B
$2.9M 0.29%
45,748
+34,943
+323% +$2.31M
2020 Q4
2 quarters

Similar funds

HighPoint Advisor Group's Q2 2021 Portfolio in Review

As of Q2 2021, HighPoint Advisor Group held 594 positions worth $993M, up 15% from $864M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

HighPoint Advisor Group deployed $92.7M of net new capital in Q2 2021, opening 70 new positions and adding to 355 existing holdings. Its largest new stake was NRX Pharmaceuticals: 4,350 shares worth $505K.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Sherwin-Williams, an estimated $4.92M trimmed.

  • HighPoint Advisor Group's largest Q2 2021 buy was NRX Pharmaceuticals: 4,350 shares worth $505K.
  • HighPoint Advisor Group added most to Microsoft in Q2 2021, an estimated $5.38M increase.
  • HighPoint Advisor Group's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $4.92M.
  • HighPoint Advisor Group fully exited FS KKR Capital Corp. II in Q2 2021, selling an estimated $3.37M.
  • HighPoint Advisor Group's ten largest holdings make up 30% of its $993M portfolio in Q2 2021.
  • HighPoint Advisor Group opened 70 new positions and closed 33 in Q2 2021.
  • HighPoint Advisor Group's portfolio value rose 15% quarter-over-quarter to $993M.

Based on HighPoint Advisor Group's 13F filing for Q2 2021, filed 29 Jul 2021.